Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 5
2007 6
2008 4
2009 10
2010 8
2011 3
2012 4
2013 2
2014 4
2015 6
2016 4
2017 6
2018 11
2019 13
2020 9
2021 10
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Results by year
Filters applied: . Clear all
Page 1
Randomized Comparison Between Radial and Femoral Large-Bore Access for Complex Percutaneous Coronary Intervention.
Meijers TA, Aminian A, van Wely M, Teeuwen K, Schmitz T, Dirksen MT, Rathore S, van der Schaaf RJ, Knaapen P, Dens J, Iglesias JF, Agostoni P, Roolvink V, Hermanides RS, van Royen N, van Leeuwen MAH. Meijers TA, et al. Among authors: van der schaaf rj. JACC Cardiovasc Interv. 2021 Jun 28;14(12):1293-1303. doi: 10.1016/j.jcin.2021.03.041. Epub 2021 May 18. JACC Cardiovasc Interv. 2021. PMID: 34020929
An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial.
Fagel ND, Amoroso G, Vink MA, Slagboom T, van der Schaaf RJ, Herrman JP, Patterson MS, Oosterwerff EFJ, Vos NS, Verheugt FWA, Tijssen JGP, de Winter RJ, Riezebos RK. Fagel ND, et al. Among authors: van der schaaf rj. Am Heart J. 2021 Apr;234:42-50. doi: 10.1016/j.ahj.2021.01.001. Epub 2021 Jan 7. Am Heart J. 2021. PMID: 33422517 Clinical Trial.
Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
Kedhi E, Verdoia M, Suryapranata H, Damen S, Camaro C, Benit E, Barbieri L, Rasoul S, Liew HB, Polad J, Ahmad WA, Zambahari R, Lalmand J, van der Schaaf RJ, Koh TH, Timmermans P Sr, Dilling-Boer D, Veenstra LF, Van' T Hof AW, Lee SW, Roolvink V, Ligtenberg E, Postma S, Kolkman EJ, Brouwer MA, Dudek D, De Luca G. Kedhi E, et al. Among authors: van der schaaf rj. Atherosclerosis. 2021 Mar;321:39-44. doi: 10.1016/j.atherosclerosis.2021.02.006. Epub 2021 Feb 16. Atherosclerosis. 2021. PMID: 33639478 Clinical Trial.
Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.
Kerkmeijer LSM, Tijssen RYG, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers APJD, Kraak RP, Onuma Y, Serruys PW, Piek JJ, Tijssen JGP, Henriques JPS, de Winter RJ, Wykrzykowska JJ. Kerkmeijer LSM, et al. Among authors: van der schaaf rj. Catheter Cardiovasc Interv. 2021 Oct;98(4):713-720. doi: 10.1002/ccd.29329. Epub 2020 Oct 29. Catheter Cardiovasc Interv. 2021. PMID: 33118696 Free PMC article. Clinical Trial.
Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion-A subanalysis of the EXPLORE trial.
Kolk MZH, van Veelen A, Agostoni P, van Houwelingen GK, Ouweneel DM, Hoebers LP, Råmunddal T, Laanmets P, Eriksen E, Bax M, Suttorp MJ, Claessen BEPM, van der Schaaf RJ, Elias J, van Dongen IM, Henriques JPS. Kolk MZH, et al. Among authors: van der schaaf rj. Catheter Cardiovasc Interv. 2021 May 1;97(6):1176-1183. doi: 10.1002/ccd.28904. Epub 2020 Apr 15. Catheter Cardiovasc Interv. 2021. PMID: 32294316 Clinical Trial.
One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis.
Fagel ND, Amoroso G, Rabbering T, Gescher F, Vink MA, Slagboom T, van der Schaaf RJ, Herrman JR, Patterson MS, Vos NS, Verbeek EC, de Winter RJ, Riezebos RK. Fagel ND, et al. Among authors: van der schaaf rj. Catheter Cardiovasc Interv. 2021 Nov 1;98(5):E661-E667. doi: 10.1002/ccd.29873. Epub 2021 Jul 15. Catheter Cardiovasc Interv. 2021. PMID: 34263520
Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial.
Verdoia M, Suryapranata H, Damen S, Camaro C, Benit E, Barbieri L, Rasoul S, Liew HB, Polad J, Ahmad WAW, Zambahari R, Lalmand J, van der Schaaf RJ, Koh TH, Timmermans P Sr, Dilling-Boer D, Veenstra LF, Van't Hof AWJ, Lee SWL, Roolvink V, Ligtenberg E, Postma S, Kolkman EJJ, Brouwer MA, Kedhi E, De Luca G. Verdoia M, et al. Among authors: van der schaaf rj. J Thromb Thrombolysis. 2021 Oct;52(3):797-807. doi: 10.1007/s11239-021-02439-x. Epub 2021 Apr 13. J Thromb Thrombolysis. 2021. PMID: 33847862 Clinical Trial.
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
Wykrzykowska JJ, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout EK, IJsselmuiden AJ, Elias J, van Dongen IM, Tijssen RYG, Koch KT, Baan J Jr, Vis MM, de Winter RJ, Piek JJ, Tijssen JGP, Henriques JPS; AIDA Investigators. Wykrzykowska JJ, et al. Among authors: van der schaaf rj. N Engl J Med. 2017 Jun 15;376(24):2319-2328. doi: 10.1056/NEJMoa1614954. Epub 2017 Mar 29. N Engl J Med. 2017. PMID: 28402237 Free article. Clinical Trial.
Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents.
Serruys PW, Katagiri Y, Sotomi Y, Zeng Y, Chevalier B, van der Schaaf RJ, Baumbach A, Smits P, van Mieghem NM, Bartorelli A, Barragan P, Gershlick A, Kornowski R, Macaya C, Ormiston J, Hill J, Lang IM, Egred M, Fajadet J, Lesiak M, Windecker S, Byrne RA, Räber L, van Geuns RJ, Mintz GS, Onuma Y. Serruys PW, et al. Among authors: van der schaaf rj. J Am Coll Cardiol. 2017 Jul 4;70(1):60-74. doi: 10.1016/j.jacc.2017.05.028. J Am Coll Cardiol. 2017. PMID: 28662808 Free article. Clinical Trial.
94 results